
Anixa Biosciences ANIX
$ 3.0
4.17%
Quarterly report 2025-Q4
added 03-09-2026
Anixa Biosciences PEG Ratio 2011-2026 | ANIX
Annual PEG Ratio Anixa Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0 | -0 | -0.000001 | -0 | -1.09 | -0.252 | -0.257 | 0.136 | 0.516 | 0.0426 | -0.233 | -0.212 | 0.03 | -0.188 | 0.0969 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.516 | -1.09 | -0.0941 |
PEG Ratio of other stocks in the Diagnostics research industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-3.07 | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
0.114 | - | -61.36 % | $ 2.46 M | ||
|
Agilent Technologies
A
|
2.05 | $ 115.55 | 3.81 % | $ 35.1 B | ||
|
CareDx, Inc
CDNA
|
-1.49 | $ 20.81 | 0.05 % | $ 1.11 B | ||
|
Co-Diagnostics
CODX
|
-0.000246 | $ 1.55 | 1.31 % | $ 2.06 M | ||
|
Castle Biosciences
CSTL
|
0.278 | $ 24.49 | 1.03 % | $ 680 M | ||
|
Akumin
AKU
|
0.0277 | - | -17.87 % | $ 25.9 M | ||
|
Biocept
BIOC
|
-0.000363 | - | -13.05 % | $ 7.29 M | ||
|
Fulgent Genetics
FLGT
|
-0.00389 | $ 15.19 | 2.64 % | $ 459 M | ||
|
Aspira Women's Health
AWH
|
-0.0104 | - | -6.19 % | $ 10.5 M | ||
|
Chembio Diagnostics
CEMI
|
-0.0363 | - | 0.22 % | $ 16.8 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
2.29 | - | - | $ 562 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.0368 | - | - | $ 9.42 M | ||
|
Heska Corporation
HSKA
|
3.41 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.00137 | - | -20.0 % | $ 1.06 M | ||
|
ICON Public Limited Company
ICLR
|
1.16 | $ 118.33 | 1.86 % | $ 9.76 B | ||
|
Illumina
ILMN
|
2.16 | $ 126.74 | 5.29 % | $ 20.2 B | ||
|
DermTech
DMTK
|
-0.847 | - | -11.32 % | $ 2.94 M | ||
|
Global Cord Blood Corporation
CO
|
0.0591 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-0.383 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
62.6 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-0.00417 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
9.49 | $ 166.97 | 1.91 % | $ 8.28 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
-2.1 | - | - | $ 10.7 B | ||
|
Lantheus Holdings
LNTH
|
-0.338 | $ 84.62 | 4.25 % | $ 5.71 B | ||
|
Enzo Biochem
ENZ
|
-0 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
-0.798 | - | - | $ 19.8 B | ||
|
Medpace Holdings
MEDP
|
0.906 | $ 418.66 | 1.23 % | $ 12.1 B | ||
|
Guardant Health
GH
|
-3.43 | $ 87.08 | 4.4 % | $ 10.9 B | ||
|
Motus GI Holdings
MOTS
|
-0.069 | - | -34.28 % | $ 263 K | ||
|
Koninklijke Philips N.V.
PHG
|
-0.461 | $ 26.34 | 2.95 % | $ 20 B | ||
|
Myriad Genetics
MYGN
|
-0.00983 | $ 4.75 | 1.5 % | $ 440 M | ||
|
Interpace Biosciences
IDXG
|
-0.00238 | $ 1.98 | -0.5 % | $ 8.76 M | ||
|
NeoGenomics
NEO
|
0.0904 | $ 9.26 | 3.35 % | $ 1.19 B | ||
|
QIAGEN N.V.
QGEN
|
3.43 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
-0.0105 | $ 2.18 | 0.93 % | $ 5.01 M | ||
|
Laboratory Corporation of America Holdings
LH
|
22.7 | $ 256.8 | -0.13 % | $ 21.4 B | ||
|
National Research Corporation
NRC
|
-7.14 | $ 16.46 | -0.48 % | $ 368 M | ||
|
Celcuity
CELC
|
-0.769 | $ 121.35 | 1.97 % | $ 5.67 B | ||
|
Natera
NTRA
|
-0.401 | $ 206.16 | 5.86 % | $ 20.3 B | ||
|
Neogen Corporation
NEOG
|
0.00738 | $ 9.4 | 4.33 % | $ 2.04 B | ||
|
Invitae Corporation
NVTA
|
0.225 | - | - | $ 21.2 M | ||
|
Quest Diagnostics Incorporated
DGX
|
6.06 | $ 194.2 | 2.58 % | $ 21.6 B | ||
|
OpGen
OPGN
|
0.00227 | - | -16.95 % | $ 1.54 M | ||
|
Organovo Holdings
ONVO
|
0.0583 | - | -2.3 % | $ 19.4 M | ||
|
PerkinElmer
PKI
|
-10.2 | - | -0.91 % | $ 14.7 B | ||
|
Exagen
XGN
|
1.93 | $ 2.9 | 5.07 % | $ 62.5 M | ||
|
Precipio
PRPO
|
-0.238 | $ 30.9 | 3.21 % | $ 49.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
0.283 | $ 17.0 | 4.68 % | $ 179 M | ||
|
Personalis
PSNL
|
-2.42 | $ 5.52 | 9.52 % | $ 327 M |